Ruby Lieshout
Rotterdam, ZH 3015CN, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification.
Journal: Molecular medicine (Cambridge, Mass.)
Published: April 22, 2022
Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL-17A.
Journal: International journal of cancer
Published: March 15, 2022
Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells.
Journal: British journal of cancer
Published: November 02, 2021
Precancerous liver diseases do not cause increased mutagenesis in liver stem cells.
Journal: Communications biology
Published: July 02, 2021
Cholangiocyte organoids from human bile retain a local phenotype and can repopulate bile ducts in vitro.
Journal: Clinical and translational medicine
Published: April 22, 2021
Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Journal: Cellular and molecular gastroenterology and hepatology
Published: March 15, 2020
Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth.
Journal: Cells
Published: December 20, 2019
Large-Scale Production of LGR5-Positive Bipotential Human Liver Stem Cells.
Journal: Hepatology (Baltimore, Md.)
Published: February 19, 2019
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 15, 2019
From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrix.
Journal: Best practice & research. Clinical gastroenterology
Published: February 15, 2017
Last Updated: 09/26/2026